Watch CNBC's interview with Eli Lilly's chief scientific officer on the new Covid antibody drug
A study found that Eli Lilly's antibody drug showed recipients had an 80 percent lower risk of symptomatic Covid-19 vs. residents in the same nursing home facility. Dr. Dan Skovronsky, Lilly Chief Scientific Officer, joins CNBC's Meg Tirrell on 'The Exchange' to discuss the trial and findings.
UP NEXT
NOW PLAYING: Video
Watch CNBC's interview with Eli Lilly's chief scientific officer on the new Covid antibody drug
CNBC
UP NEXT
-
Moderna CEO talks Covid vaccine for new South African variant
CNBC
-
Post-Market Wrap: February 24, 2021
-
CNBC Tech Check Evening Edition: February 24, 2021
-
ETF Edge, February 24, 2021
-
The mechanics behind two of the most popular space-related ETFs
-
Breaking down Nvidia's fourth-quarter results
-
What Queen Cathie's moves in the ARK ETF mean for the individual stocks
-
Tilray-Aphria merger will create the largest retail cannabis company in the world, says Aphria CEO
-
CNBC Markets Now: February 24, 2021
-
Biden signs executive order to streamline chip supply chain
-
Nvidia's numbers look great, says Bernstein's Rasgon
-
Nvidia beats on top and bottom
-
Moderna plans to test booster doses of variant-specific vaccine for NIH study
-
ViacomCBS earnings beat estimates
-
Booking Holdings beats on revenue
-
The Dow's record close and the 'different' type of money now in the markets
![image beacon](https://web.vortex.data.msn.com/collect/v1/t.gif?name=%27Ms.Webi.PageView%27&ver=%272.1%27&appId=%27JS%3AMSN%27&ext-app-env=%27prod%27&ext-javascript-libver=%274.0.0-beta-10%27&ext-user-localId=%27t%3A3895A25378AD6B291AB2ADBA791A6A5C%27&*baseType=%27Ms.Content.PageView%27&*isJs=False&*title=%27%27&*isLoggedIn=False&*isManual=True&*serverImpressionGuid=%27c56935a8-6140-4b25-ba9f-802114b37aeb%27&-ver=%271.0%27&-impressionGuid=%27c56935a8-6140-4b25-ba9f-802114b37aeb%27&-pageName=%27channelplayerpage%27&-uri=%27http%253A%252F%252Fwww.msn.com%252Fen-us%252Fmoney%252Fvideo%252Fwatch-cnbcs-interview-with-eli-lillys-chief-scientific-officer-on-the-new-covid-antibody-drug%252Fvp-BB1cYrKK%27&-referrerUri=%27%27&-pageTags=%27{"pg.t"%3A"video"%2C"pg.p"%3A"prime"%2C"pg.c"%3A""%2C"ex"%3A""%2C"rid"%3A"c56935a861404b25ba9f802114b37aeb"%2C"clid"%3A"3895A25378AD6B291AB2ADBA791A6A5C"%2C"clidType"%3A"muid"%2C"di"%3A"7290"%2C"partner"%3A"CNBC"%2C"publcat"%3A"CNBC%2BLLC"%2C"cvs"%3A"Browser"%2C"subcvs"%3A"finance"%2C"entityId"%3A"BB1cYrKK"%2C"entitySrc"%3A"vp"%2C"provid"%3A"AAnPvW"%2C"dpt"%3A"finance-video"%2C"sdpt"%3A""%2C"ar"%3A"0"%2C"dgk"%3A"downlevel.pc"%2C"imd"%3A"0"%2C"parentId"%3A""%2C"pgIdx"%3A""%2C"pgTot"%3A""%2C"anoncknm"%3A""%2C"afd"%3A""%2C"issso"%3A"0"%2C"aadState"%3A"0"}%27&-behavior=0&-market=%27en-us%27){kind=small}